APP and Alzheimer disease: EHT1864 can block the Rac1-dependent processing of amyloid precursor protein, and amyloid precursor protein forms senile plaque of Alzheimer’s disease (AD), which provides a prototype for developing new drugs suitable for AD therapy (197).